Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease

Mov Disord. 2022 Jun;37(6):1284-1289. doi: 10.1002/mds.28986. Epub 2022 Mar 11.

Abstract

Background: The neurophysiological correlates of gastrointestinal symptoms (GISs) in Parkinson's disease (PD) are not well understood. It has been proposed that in patients with a gastrointestinal origin of PD dopaminergic neurodegeneration would be more symmetric.

Objectives: The aim is to assess the associations between GISs and asymmetry of nigrostriatal dopaminergic neurodegeneration in PD.

Methods: Ninety PD patients were assessed using motor and GIS scales and 123 I-FP-CIT SPECT. We calculated the asymmetry index and the predominant side of motor symptoms and dopamine transporter (DAT) imaging defect and assessed their association with GISs.

Results: There were no significant differences in GISs between symmetric and asymmetric dopaminergic defect. Left predominant defect was related to more GIS and higher constipation scores.

Conclusions: GISs were associated with left predominant reduction in putaminal DAT binding but not asymmetry per se. It remains open whether left-sided DAT deficit is related to more pronounced GI involvement or symptom perception in PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson Movement Disorder Society.

Keywords: Parkinson's diseasegastrointestinal symptomsdopamine transporter.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Corpus Striatum / metabolism
  • Dopamine / metabolism
  • Dopamine Plasma Membrane Transport Proteins* / metabolism
  • Humans
  • Parkinson Disease* / complications
  • Parkinson Disease* / diagnostic imaging
  • Parkinson Disease* / metabolism
  • Tomography, Emission-Computed, Single-Photon / methods
  • Tropanes / metabolism

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Tropanes
  • Dopamine